Patents by Inventor MARY L. FABER

MARY L. FABER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multiple Myeloma Mapping and Uses Thereof
    Publication number: 20230280344
    Abstract: The present invention provides methods and kits for detecting and treating multiple myeloma. The methods involve detecting proteins that the inventors have identified as biomarkers of multiple melanoma.
    Type: Application
    Filed: July 15, 2021
    Publication date: September 7, 2023
    Inventors: Jeffrey A. Medin, Robyn A. Oldham, Mary L. Faber, Rebekah L. Gundry
  • Anti-CD30 Antibodies and Methods for Treating CD30+ Cancer
    Publication number: 20230235071
    Abstract: The present invention provides novel antibodies and antigen binding fragments thereof that bind to human CD30. Also presented are single chain variable antibodies, chimeric antigen receptors and uses thereof. Methods of treating cancer are also disclosed.
    Type: Application
    Filed: February 2, 2023
    Publication date: July 27, 2023
    Inventors: Jeffrey A. Medin, Mary L. Faber, Everett R. Tate, Robyn A.A. Oldham
  • Anti-CD30 antibodies and methods for treating CD30+ cancer
    Patent number: 11584799
    Abstract: The present invention provides novel antibodies and antigen binding fragments thereof that bind to human CD30. Also presented are single chain variable antibodies, chimeric antigen receptors and uses thereof. Methods of treating cancer are also disclosed.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: February 21, 2023
    Assignees: Medical College of Wisconsin, Inc., University of Virginia Patent Foundation
    Inventors: Jeffrey A. Medin, Mary L. Faber, Everett R. Tate, Robyn A. A. Oldham
  • ANTI-CD30 ANTIBODIES AND METHODS OF USE
    Publication number: 20200095329
    Abstract: The present invention provides novel antibodies and antigen binding fragments thereof that bind to human CD30. Also presented are single chain variable antibodies, chimeric antigen receptors and uses thereof. Methods of treating cancer are also disclosed.
    Type: Application
    Filed: September 24, 2019
    Publication date: March 26, 2020
    Inventors: JEFFREY A. MEDIN, MARY L. FABER, EVERETT R. TATE, ROBYN A.A. OLDHAM